{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:28:37Z","timestamp":1784770117447,"version":"3.55.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIHR Yorkshire and Humber strategic funding","award":["2021-014-HEICOVID & Us - VACCINE & Restart."],"award-info":[{"award-number":["2021-014-HEICOVID & Us - VACCINE & Restart."]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The Covid-19 pandemic had a profound effect on the delivery of healthcare research. Covid-19 research was prioritised and many non-essential trials were paused. This study explores the engagement experiences of trial participants\u2019, PPIE contributors\u2019 and trial staff during the Covid-19 pandemic and towards recovery and restoring a diverse and balanced UK clinical trials portfolio.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Interviews and focus groups were undertaken with PPIE contributors, trial participants and trial staff members from NIHR research trials across the UK (November 2020-June 2021) across portfolio specialities: Cancer, Oral and Dental Health, Musculoskeletal Disorders, Cardiovascular Disease, Neurological Disorders, Primary Care, and Conditions associated with susceptibility to Covid-19 (Diabetes, Stroke, Respiratory Disorders). Topic guides were developed for each participant group and interviews were conducted over Zoom. The transcripts were analysed using codebook thematic analysis in NVivo (V.12).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>106 participants comprising, 45 PPIE contributors, 27 trial participants and 34 trial staff members were recruited. Three themes to engagement with trials during Covid-19 were developed. <jats:italic>1) Ensuring continued contact<\/jats:italic>. Continued and tailored communication, having a trial point of contact and regular updates all enhanced trial engagement and retention. Patients\u2019 unfamiliarity with materials being sent electronically reduced engagement and trust. <jats:italic>2) A balanced move to remote consultations<\/jats:italic>. Remote follow-up and monitoring were convenient and allowed for wider recruitment across the UK. Participants were more likely to discuss personal subjects in their own homes. Remote visits lacked a personal touch, some concerns over missed diagnoses or being unable to appreciate the situation, technical abilities or equipment failures were seen as barriers, especially for disadvantaged or older people. <jats:italic>3) The importance of feeling fully informed<\/jats:italic>. Factors that supported attendance were knowledge about trial conduct adherence to Covid-19 regulations, social distancing, clear signage at the site and opportunities to ask questions. Barriers included not knowing what to expect and not feeling safe with rules and regulations.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our findings highlight a number of ways to future proof trial delivery against future pandemics or disruptions such as offering online options to participate in research, ensuring consistent communication between participants and the research team, making sure participants feel fully informed and the continued reassurance of safety in the clinical setting.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0296343","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T18:31:08Z","timestamp":1708540268000},"page":"e0296343","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8708-9842","authenticated-orcid":true,"given":"Heather","family":"Leggett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6362-9824","authenticated-orcid":true,"given":"Karen","family":"Vinall-Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-9762","authenticated-orcid":true,"given":"Julia","family":"Csikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophy","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6972-0100","authenticated-orcid":true,"given":"Rachel","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrit","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Pavitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"issue":"8","key":"pone.0296343.ref001","doi-asserted-by":"crossref","first-page":"e0256871","DOI":"10.1371\/journal.pone.0256871","article-title":"Impacts of COVID-19 on clinical research in the UK: a multi-method qualitative case study","volume":"16","author":"D Wyatt","year":"2021","journal-title":"PLoS One"},{"issue":"8","key":"pone.0296343.ref002","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ajic.2020.05.017","article-title":"The effect of state-level stay-at-home orders on COVID-19 infection rates","volume":"48","author":"RC Castillo","year":"2020","journal-title":"American journal of infection control"},{"key":"pone.0296343.ref003","first-page":"1","article-title":"COVID-19: the relationship between perceptions of risk and behaviours during lockdown","author":"R Brown","year":"2021","journal-title":"Journal of Public Health"},{"key":"pone.0296343.ref004","year":"2020","journal-title":"NIHR shares first update on implementation of the Restart Framework"},{"issue":"1","key":"pone.0296343.ref005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jamaoncol.2020.5748","article-title":"Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical Trials.","volume":"7","author":"ME Fleury","year":"2021","journal-title":"JAMA Oncology"},{"issue":"1","key":"pone.0296343.ref006","first-page":"1","article-title":"Why do patients take part in research? An overview of systematic reviews of psychosocial barriers and facilitators.","volume":"21","author":"R Sheridan","year":"2020","journal-title":"Trials"},{"issue":"12","key":"pone.0296343.ref007","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/oby.23016","article-title":"COVID\u201019 impacts mental health outcomes and ability\/desire to participate in research among current research participants.","volume":"28","author":"MI Cardel","year":"2020","journal-title":"Obesity"},{"key":"pone.0296343.ref008","author":"National Institute for Health Research","journal-title":"DHSC issues guidance on the impact of COVID-19 on research funded or supported by NIHR 16\/03\/21"},{"issue":"5","key":"pone.0296343.ref009","doi-asserted-by":"crossref","first-page":"e0251410","DOI":"10.1371\/journal.pone.0251410","article-title":"The impact of COVID-19 on the clinical trial.","volume":"16","author":"Z Chen","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"pone.0296343.ref010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/2159676X.2019.1704846","article-title":"To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales.","volume":"13","author":"V Braun","year":"2021","journal-title":"Qualitative Research in Sport, Exercise and Health."},{"issue":"1","key":"pone.0296343.ref011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1037\/qup0000196","article-title":"Conceptual and design thinking for thematic analysis.","volume":"9","author":"V Braun","year":"2022","journal-title":"Qualitative Psychology."},{"key":"pone.0296343.ref012","article-title":"Timeline of UK government coronavirus lockdowns and measures, March 2020 to December 2021","year":"2022","journal-title":"Institute for Government analysis"},{"issue":"1","key":"pone.0296343.ref013","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/s13063-018-2916-9","article-title":"Patients\u2019 reasoning regarding the decision to participate in clinical cancer trials: an interview study","volume":"19","author":"P Dellson","year":"2018","journal-title":"Trials"},{"key":"pone.0296343.ref014","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2147\/PPA.S263022","article-title":"Optimizing the Communication with Cancer Patients During the COVID-19 Pandemic: Patient Perspectives.","volume":"14","author":"E Tashkandi","year":"2020","journal-title":"Patient Prefer Adherence."},{"key":"pone.0296343.ref015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.puhe.2019.07.005","article-title":"What the public think about participation in medical research during an influenza pandemic: an international cross-sectional survey.","volume":"177","author":"N Gobat","year":"2019","journal-title":"Public Health."},{"issue":"7","key":"pone.0296343.ref016","doi-asserted-by":"crossref","first-page":"151287","DOI":"10.1016\/j.semperi.2020.151287","article-title":"Conducting research during the COVID-19 pandemic.","volume":"44","author":"M Mourad","year":"2020","journal-title":"Semin Perinatol"},{"issue":"9","key":"pone.0296343.ref017","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1007\/s00259-020-04910-y","article-title":"Impact of the COVID-19 crisis on imaging in oncological trials","volume":"47","author":"CM Deroose","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"pone.0296343.ref018","doi-asserted-by":"crossref","first-page":"e29691","DOI":"10.2196\/29691","article-title":"Patients\u2019 Perspectives on Transforming Clinical Trial Participation: Large Online Vignette-based Survey.","volume":"24","author":"VT Nguyen","year":"2022","journal-title":"J Med Internet Res"},{"issue":"5","key":"pone.0296343.ref019","doi-asserted-by":"crossref","first-page":"505","DOI":"10.6004\/jnccn.2020.7643","article-title":"Experience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research Adjustments","volume":"19","author":"DE Gerber","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"pone.0296343.ref020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/apc.2021.0075","article-title":"Transitioning to Telehealth During the COVID-19 Pandemic: Patient Perspectives and Attendance at an HIV Clinic in San Francisco","volume":"35","author":"IC Auchus","year":"2021","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"pone.0296343.ref021","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2020.04.055","article-title":"Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients\u2019 Perspective.","volume":"78","author":"K Boehm","year":"2020","journal-title":"Eur Urol."},{"issue":"6","key":"pone.0296343.ref022","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1111\/jgs.16500","article-title":"Participant and Caregiver Perspectives on Clinical Research During Covid-19 Pandemic.","volume":"68","author":"PR Padala","year":"2020","journal-title":"J Am Geriatr Soc."},{"issue":"3","key":"pone.0296343.ref023","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/bcp.14480","article-title":"The impact of the global COVID-19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis","volume":"87","author":"M Vissers","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"pone.0296343.ref024","doi-asserted-by":"crossref","first-page":"e1013","DOI":"10.1634\/theoncologist.2020-0316","article-title":"Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak.","volume":"25","author":"G Viale","year":"2020","journal-title":"Oncologist"},{"issue":"6","key":"pone.0296343.ref025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jacr.2020.03.027","article-title":"Operational Strategies to Prevent Coronavirus Disease 2019 (COVID-19) Spread in Radiology: Experience From a Singapore Radiology Department After Severe Acute Respiratory Syndrome.","volume":"17","author":"Y Goh","year":"2020","journal-title":"J Am Coll Radiol."},{"issue":"2","key":"pone.0296343.ref026","doi-asserted-by":"crossref","first-page":"E106","DOI":"10.1148\/radiol.2020200988","article-title":"Radiology Department Preparedness for COVID-19: Radiology Scientific Expert Review Panel.","volume":"296","author":"M Mossa-Basha","year":"2020","journal-title":"Radiology"},{"issue":"9","key":"pone.0296343.ref027","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/jnci\/90.9.668","article-title":"Informed Consent for Clinical Trials: a Comparative Study of Standard Versus Simplified Forms","volume":"90","author":"TC Davis","year":"1998","journal-title":"JNCI: Journal of the National Cancer Institute."},{"issue":"2","key":"pone.0296343.ref028","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/10901981221116791","article-title":"Using Animated Videos to Increase Patient Knowledge: A Meta-Analytic Review.","volume":"50","author":"TH Feeley","year":"2023","journal-title":"Health Education & Behavior."},{"issue":"10","key":"pone.0296343.ref029","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/10810730.2019.1668089","article-title":"Animations about Clinical Trial Participation for Cancer Patients and Survivors","volume":"24","author":"A Occa","year":"2019","journal-title":"Journal of Health Communication"},{"key":"pone.0296343.ref030","year":"2021","journal-title":"NIHR issues final update on implementation of the Restart Framework"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0296343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T18:31:35Z","timestamp":1708540295000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0296343"}},"subtitle":[],"editor":[{"given":"Saiendhra Vasudevan","family":"Moodley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0296343","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]}}}